GRI Bio Inc (GRI)

Healthcare | Biotechnology
Income Statement (Quarterly) 2025-07-31 2025-01-31 2024-12-31 2024-10-31
Revenue 0 2,298,000 0 0
Cost of Revenue 1,000 0 0 0
Gross Profit -1,000 2,298,000 0 0
Operating Expenses
R&D Expenses 0 0 0 0
SG&A Expenses 1,018,000 1,125,000 1,125,000 1,000,000
Operating Expenses 2,897,000 1,954,000 1,953,000 2,130,000
Operating Income -2,897,000 -1,954,000 -1,953,000 -2,130,000
Interest Expense 0 0 0 0
Income Before Tax -2,892,000 -1,948,000 -1,947,000 -2,123,000
Income Tax Expense 0 0 0 0
Net Income -2,892,000 -1,948,000 -1,947,000 -2,123,000
Per Share
EPS -1.31 -0.40 140.81 -11.42
EPS Diluted 0.00 0.00 0.00 0.00
Income Statement (Annual) 2024-12-31 2023-12-31 2022-12-31
Revenue 22,538,000 0 0
Cost of Revenue 11,628,000 0 206,000
Gross Profit 10,910,000 0 -206,000
Operating Expenses
R&D Expenses 0 0 0
SG&A Expenses 4,467,000 8,155,000 1,997,000
Operating Expenses 8,235,000 11,387,000 2,239,000
Operating Income -8,235,000 -11,387,000 -2,239,000
Interest Expense -6,000 2,082,000 653,000
Income Before Tax -8,207,000 -13,037,000 -3,217,000
Income Tax Expense 0 0 325,000
Net Income -8,207,000 -13,037,000 -3,542,000
Per Share
EPS -55.21 -6,242.18 -823.76
EPS Diluted 0.00 0.00 0.00
Balance Sheet (Quarterly) 2024-12-31 2023-12-31 2022-12-31
Assets
Cash and Cash Equivalents 5,028,000 1,808,000 9,000
Short Term Investments 0 0 0
Net Receivables 0 0 0
Inventory 0 0 0
Total Current Assets 5,615,000 2,934,000 308,000
Property Plant Equipment 124,000 22,000 71,000
Goodwill and Intangibles 0 0 0
Total Assets 5,739,000 2,956,000 383,000
Liabilities
Account Payables 897,000 1,410,000 1,294,000
Short Term Debt 96,000 14,000 659,000
Total Current Liabilities 1,636,000 2,697,000 1,994,000
Long Term Debt 71,000 0 14,000
Total Liabilities 1,707,000 2,697,000 2,008,000
Shareholders Equity
Retained Earnings -39,740,000 -31,533,000 -18,496,000
Total Shareholders Equity 4,032,000 259,000 -1,625,000
Balance Sheet (Annual) 2024-12-31 2023-12-31 2022-12-31
Assets
Cash and Cash Equivalents 5,028,000 1,808,000 9,000
Short Term Investments 0 0 0
Net Receivables 0 0 0
Inventory 0 0 0
Total Current Assets 5,615,000 2,934,000 308,000
Property Plant Equipment 124,000 22,000 71,000
Goodwill and Intangibles 0 0 0
Total Assets 5,739,000 2,956,000 383,000
Liabilities
Account Payables 897,000 1,410,000 1,294,000
Short Term Debt 96,000 14,000 659,000
Total Current Liabilities 1,636,000 2,697,000 1,994,000
Long Term Debt 71,000 0 14,000
Total Liabilities 1,707,000 2,697,000 2,008,000
Shareholders Equity
Retained Earnings -39,740,000 -31,533,000 -18,496,000
Total Shareholders Equity 4,032,000 259,000 -1,625,000
Cash Flow Statement (Quarterly) 2024-12-31 2023-12-31 2022-12-31
Operating Activities
Net Income -8,207,000 -13,037,000 -3,217,000
Depreciation & Amortization 4,000 57,000 50,000
Stock Based Compensation 0 388,000 25,000
Change in Working Capital -448,000 1,680,000 1,515,000
Operating Cash Flow -8,611,000 -9,140,000 -1,085,000
Investing Activities
Capital Expenditure 0 -8,000 -3,000
Investments -396,000 -8,000 -3,000
Investing Cash Flow 0 -8,000 -3,000
Financing Activities
Debt Repayment 0 -1,250,000 -250,000
Common Stock Issued/Repurchased 13,102,000 11,745,000 3,323,000
Dividends Paid 0 -2,915,000 -3,447,000
Financing Cash Flow 11,831,000 10,947,000 1,007,000
Summary
Free Cash Flow -8,611,000 -9,148,000 -1,088,000
Net Change in Cash 3,220,000 1,799,000 -81,000
Cash Flow Statement (Annual) 2024-12-31 2023-12-31 2022-12-31
Operating Activities
Net Income -8,207,000 -13,037,000 -3,217,000
Depreciation & Amortization 4,000 57,000 50,000
Stock Based Compensation 0 388,000 25,000
Change in Working Capital -448,000 1,680,000 1,515,000
Operating Cash Flow -8,611,000 -9,140,000 -1,085,000
Investing Activities
Capital Expenditure 0 -8,000 -3,000
Investments -396,000 -8,000 -3,000
Investing Cash Flow 0 -8,000 -3,000
Financing Activities
Debt Repayment 0 -1,250,000 -250,000
Common Stock Issued/Repurchased 13,102,000 11,745,000 3,323,000
Dividends Paid 0 -2,915,000 -3,447,000
Financing Cash Flow 11,831,000 10,947,000 1,007,000
Summary
Free Cash Flow -8,611,000 -9,148,000 -1,088,000
Net Change in Cash 3,220,000 1,799,000 -81,000